Xiaodong Yang is the founder of Apexigen. Apexigen has raised $158M in total funding. Latest round: Series C. Based in San Carlos, California.
Xiaodong Yang founded Apexigen in 2010 as a spin-out from Epitomics. Apexigen is a clinical-stage biopharmaceutical company based in San Carlos, California, focused on discovering and developing humanized monoclonal antibody therapeutics for oncology applications using its proprietary APXiMAB platform. The company raised over $150 million in private venture funding before merging with SPAC Brookline Capital Acquisition Corp in 2022 to go public. It was later acquired by Pyxis Oncology for approximately $10.7 million in August 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library